Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in Metastatic Non-clear Cell RCC Previously Treated With Temsirolimus
NCT01798446Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Seoul National University Hospital. Started Feb 2013; status: completed.
02
Drugs
axitinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01798446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798446.